-
1
-
-
85018198613
-
Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction
-
28192102 1:CAS:528:DC%2BC2sXms1CntLc%3D
-
Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology. 2017;152(7):1671-8.
-
(2017)
Gastroenterology
, vol.152
, Issue.7
, pp. 1671-1678
-
-
Bouter, K.E.1
Van Raalte, D.H.2
Groen, A.K.3
Nieuwdorp, M.4
-
2
-
-
85040811564
-
Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity
-
1:CAS:528:DC%2BC1cXhvVemurw%3D
-
Gao R, Zhu C, Li H, Yin M, Pan C, Huang L, Kong C, Wang X, Zhang Y, Qu S, et al. Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obesity (Silver Spring). 2018;26(2):351-61.
-
(2018)
Obesity (Silver Spring)
, vol.26
, Issue.2
, pp. 351-361
-
-
Gao, R.1
Zhu, C.2
Li, H.3
Yin, M.4
Pan, C.5
Huang, L.6
Kong, C.7
Wang, X.8
Zhang, Y.9
Qu, S.10
-
3
-
-
84883181684
-
Human gut microbiota changes reveal the progression of glucose intolerance
-
e71108 24013136 3754967 1:CAS:528:DC%2BC3sXhsVWhsbfP
-
Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8(8):e71108.
-
(2013)
PLoS One
, vol.8
, Issue.8
-
-
Zhang, X.1
Shen, D.2
Fang, Z.3
Jie, Z.4
Qiu, X.5
Zhang, C.6
Chen, Y.7
Ji, L.8
-
4
-
-
85030998140
-
Effects of Antidiabetic Drugs on Gut Microbiota Composition
-
Montandon SA, Jornayvaz FR. Effects of Antidiabetic Drugs on Gut Microbiota Composition. Genes (Basel). 2017;8(10). https://doi.org/10.3390/genes8100250.
-
(2017)
Genes (Basel)
, vol.8
, Issue.10
-
-
Montandon, S.A.1
Jornayvaz, F.R.2
-
5
-
-
85037666947
-
Systematic review: Human gut dysbiosis induced by non-antibiotic prescription medications
-
29205415 1:STN:280:DC%2BC1M3nvFKrtw%3D%3D
-
Le Bastard Q, Al-Ghalith GA, Gregoire M, Chapelet G, Javaudin F, Dailly E, Batard E, Knights D, Montassier E. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment Pharmacol Ther. 2018;47(3):332-45.
-
(2018)
Aliment Pharmacol Ther
, vol.47
, Issue.3
, pp. 332-345
-
-
Le Bastard, Q.1
Al-Ghalith, G.A.2
Gregoire, M.3
Chapelet, G.4
Javaudin, F.5
Dailly, E.6
Batard, E.7
Knights, D.8
Montassier, E.9
-
6
-
-
84892828465
-
Diet rapidly and reproducibly alters the human gut microbiome
-
24336217 1:CAS:528:DC%2BC2cXhtFOls78%3D
-
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559-63.
-
(2014)
Nature
, vol.505
, Issue.7484
, pp. 559-563
-
-
David, L.A.1
Maurice, C.F.2
Carmody, R.N.3
Gootenberg, D.B.4
Button, J.E.5
Wolfe, B.E.6
Ling, A.V.7
Devlin, A.S.8
Varma, Y.9
Fischbach, M.A.10
-
7
-
-
80053618114
-
Linking long-term dietary patterns with gut microbial enterotypes
-
21885731 3368382 1:CAS:528:DC%2BC3MXht1Gms77K
-
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334(6052):105-8.
-
(2011)
Science
, vol.334
, Issue.6052
, pp. 105-108
-
-
Wu, G.D.1
Chen, J.2
Hoffmann, C.3
Bittinger, K.4
Chen, Y.Y.5
Keilbaugh, S.A.6
Bewtra, M.7
Knights, D.8
Walters, W.A.9
Knight, R.10
-
8
-
-
84908080513
-
The target of metformin in type 2 diabetes
-
25317875 1:CAS:528:DC%2BC2cXitVSls7%2FF
-
Ferrannini E. The target of metformin in type 2 diabetes. N Engl J Med. 2014;371(16):1547-8.
-
(2014)
N Engl J Med
, vol.371
, Issue.16
, pp. 1547-1548
-
-
Ferrannini, E.1
-
9
-
-
44649106470
-
Role of metformin for weight management in patients without type 2 diabetes
-
18477733 1:CAS:528:DC%2BD1cXnsFKqsLc%3D
-
Desilets AR, Dhakal-Karki S, Dunican KC. Role of metformin for weight management in patients without type 2 diabetes. Ann Pharmacother. 2008;42(6):817-26.
-
(2008)
Ann Pharmacother
, vol.42
, Issue.6
, pp. 817-826
-
-
Desilets, A.R.1
Dhakal-Karki, S.2
Dunican, K.C.3
-
10
-
-
85021184058
-
Effect of metformin on different non-diabetes related conditions, a special focus on malignant conditions: Review of literature
-
28392858 5380171 1:CAS:528:DC%2BC1cXhvFyksr%2FJ
-
Abdelgadir E, Ali R, Rashid F, Bashier A. Effect of metformin on different non-diabetes related conditions, a special focus on malignant conditions: review of literature. J Clin Med Res. 2017;9(5):388-95.
-
(2017)
J Clin Med Res
, vol.9
, Issue.5
, pp. 388-395
-
-
Abdelgadir, E.1
Ali, R.2
Rashid, F.3
Bashier, A.4
-
11
-
-
85021320590
-
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
-
28530702 1:CAS:528:DC%2BC2sXotVOluro%3D
-
Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manneras-Holm L, Stahlman M, Olsson LM, Serino M, Planas-Felix M, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850-8.
-
(2017)
Nat Med
, vol.23
, Issue.7
, pp. 850-858
-
-
Wu, H.1
Esteve, E.2
Tremaroli, V.3
Khan, M.T.4
Caesar, R.5
Manneras-Holm, L.6
Stahlman, M.7
Olsson, L.M.8
Serino, M.9
Planas-Felix, M.10
-
12
-
-
85020279172
-
Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis
-
28673568 1:CAS:528:DC%2BC2sXpslWjsrg%3D
-
Maniar K, Moideen A, Bhattacharyya R, Banerjee D. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: a hypothesis. Med Hypotheses. 2017;104:117-20.
-
(2017)
Med Hypotheses
, vol.104
, pp. 117-120
-
-
Maniar, K.1
Moideen, A.2
Bhattacharyya, R.3
Banerjee, D.4
-
13
-
-
84949772416
-
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
-
26633628 4681099 1:CAS:528:DC%2BC2MXhvFemsbjN
-
Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262-6.
-
(2015)
Nature
, vol.528
, Issue.7581
, pp. 262-266
-
-
Forslund, K.1
Hildebrand, F.2
Nielsen, T.3
Falony, G.4
Le Chatelier, E.5
Sunagawa, S.6
Prifti, E.7
Vieira-Silva, S.8
Gudmundsdottir, V.9
Pedersen, H.K.10
-
14
-
-
85049260517
-
Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: A cross-sectional study in subjects with morbid obesity
-
29299330 5745623
-
Winther R, Aasbrenn M, Farup PG. Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity. BMC Obes. 2017;4:41.
-
(2017)
BMC Obes
, vol.4
, pp. 41
-
-
Winther, R.1
Aasbrenn, M.2
Farup, P.G.3
-
15
-
-
84908325271
-
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
-
25231862 1:CAS:528:DC%2BC2cXhslaqs7zK
-
Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181-6.
-
(2014)
Nature
, vol.514
, Issue.7521
, pp. 181-186
-
-
Suez, J.1
Korem, T.2
Zeevi, D.3
Zilberman-Schapira, G.4
Thaiss, C.A.5
Maza, O.6
Israeli, D.7
Zmora, N.8
Gilad, S.9
Weinberger, A.10
-
16
-
-
84908325425
-
Health: The weighty costs of non-caloric sweeteners
-
25231865 4449731 1:CAS:528:DC%2BC2cXhslaqs7%2FM
-
Feehley T, Nagler CR. Health: the weighty costs of non-caloric sweeteners. Nature. 2014;514(7521):176-7.
-
(2014)
Nature
, vol.514
, Issue.7521
, pp. 176-177
-
-
Feehley, T.1
Nagler, C.R.2
-
17
-
-
84907731370
-
Sugar substitutes linked to obesity
-
25230625 1:CAS:528:DC%2BC2cXhsFOksr7J
-
Abbott A. Sugar substitutes linked to obesity. Nature. 2014;513(7518):290.
-
(2014)
Nature
, vol.513
, Issue.7518
, pp. 290
-
-
Abbott, A.1
-
18
-
-
85038859799
-
Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity
-
Aasbrenn M, Valeur J, Farup PG. Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity. Scand J Clin Lab Invest. 2018;76(1-2):109-13.
-
(2018)
Scand J Clin Lab Invest
, vol.76
, Issue.1-2
, pp. 109-113
-
-
Aasbrenn, M.1
Valeur, J.2
Farup, P.G.3
-
19
-
-
85008512158
-
Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis
-
27300149
-
Zhuang X, Xiong L, Li L, Li M, Chen M. Alterations of gut microbiota in patients with irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32(1):28-38.
-
(2017)
J Gastroenterol Hepatol
, vol.32
, Issue.1
, pp. 28-38
-
-
Zhuang, X.1
Xiong, L.2
Li, L.3
Li, M.4
Chen, M.5
-
20
-
-
84905716488
-
A role for the gut microbiota in IBS
-
24751910 1:CAS:528:DC%2BC2cXmslansLk%3D
-
Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11(8):497-505.
-
(2014)
Nat Rev Gastroenterol Hepatol
, vol.11
, Issue.8
, pp. 497-505
-
-
Collins, S.M.1
-
22
-
-
85028323483
-
Stress and stability: Applying the Anna Karenina principle to animal microbiomes
-
28836573 1:CAS:528:DC%2BC2sXhtlyit7vK
-
Zaneveld JR, McMinds R, Vega Thurber R. Stress and stability: applying the Anna Karenina principle to animal microbiomes. Nat Microbiol. 2017;2:17121.
-
(2017)
Nat Microbiol
, vol.2
, pp. 17121
-
-
Zaneveld, J.R.1
McMinds, R.2
Vega Thurber, R.3
-
23
-
-
84930486219
-
Deviations in human gut microbiota: A novel diagnostic test for determining dysbiosis in patients with IBS or IBD
-
25973666 5029765 1:CAS:528:DC%2BC2MXpvVeitLo%3D
-
Casen C, Vebo HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Froyland C, Nestestog R, Engstrand L, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42(1):71-83.
-
(2015)
Aliment Pharmacol Ther
, vol.42
, Issue.1
, pp. 71-83
-
-
Casen, C.1
Vebo, H.C.2
Sekelja, M.3
Hegge, F.T.4
Karlsson, M.K.5
Ciemniejewska, E.6
Dzankovic, S.7
Froyland, C.8
Nestestog, R.9
Engstrand, L.10
-
24
-
-
85058946658
-
-
Genetic Analysis AS. GAMap TM Dysbiosis Test Accessed 31 July 2018
-
Genetic Analysis AS. GAMap TM Dysbiosis Test [ http://www.genetic-analysis.com/patent ] Accessed 31 July 2018.
-
-
-
-
25
-
-
0030942155
-
The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress
-
9146781 1:STN:280:DyaK2s3pt1answ%3D%3D
-
Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395-402.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, Issue.2
, pp. 395-402
-
-
Francis, C.Y.1
Morris, J.2
Whorwell, P.J.3
-
26
-
-
85058928588
-
-
Norwegian Food Safety Authority. Food Database Accessed 31 July 2018
-
Norwegian Food Safety Authority. Food Database [ http://www.matvaretabellen.no/?language=en ]. Accessed 31 July 2018.
-
-
-
-
27
-
-
84928168588
-
Non-caloric artificial sweeteners and the microbiome: Findings and challenges
-
25831243 4615743 1:CAS:528:DC%2BC28XhsVyltrc%3D
-
Suez J, Korem T, Zilberman-Schapira G, Segal E, Elinav E. Non-caloric artificial sweeteners and the microbiome: findings and challenges. Gut Microbes. 2015;6(2):149-55.
-
(2015)
Gut Microbes
, vol.6
, Issue.2
, pp. 149-155
-
-
Suez, J.1
Korem, T.2
Zilberman-Schapira, G.3
Segal, E.4
Elinav, E.5
-
28
-
-
84986596815
-
Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome
-
Sze MA, Schloss PD. Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome. MBio. 2016:7(4). https://doi.org/10.1128/mBio.01018-16.
-
(2016)
MBio
, vol.7
, Issue.4
-
-
Ma, S.1
Schloss, P.D.2
-
29
-
-
84903524608
-
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
-
24847880 4074244 1:CAS:528:DC%2BC2cXpslGitLg%3D
-
Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542-6.
-
(2014)
Nature
, vol.510
, Issue.7506
, pp. 542-546
-
-
Madiraju, A.K.1
Erion, D.M.2
Rahimi, Y.3
Zhang, X.M.4
Braddock, D.T.5
Albright, R.A.6
Prigaro, B.J.7
Wood, J.L.8
Bhanot, S.9
Macdonald, M.J.10
-
30
-
-
0021362746
-
Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects
-
6373159 1:CAS:528:DyaL2MXks1Clurw%3D
-
Bonora E, Cigolini M, Bosello O, Zancanaro C, Capretti L, Zavaroni I, Coscelli C, Butturini U. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects. Curr Med Res Opin. 1984;9(1):47-51.
-
(1984)
Curr Med Res Opin
, vol.9
, Issue.1
, pp. 47-51
-
-
Bonora, E.1
Cigolini, M.2
Bosello, O.3
Zancanaro, C.4
Capretti, L.5
Zavaroni, I.6
Coscelli, C.7
Butturini, U.8
-
31
-
-
0026541437
-
The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes
-
1551312 1:STN:280:DyaK383gtVyluw%3D%3D
-
Sum CF, Webster JM, Johnson AB, Catalano C, Cooper BG, Taylor R. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes. Diabet Med. 1992;9(1):61-5.
-
(1992)
Diabet Med
, vol.9
, Issue.1
, pp. 61-65
-
-
Sum, C.F.1
Webster, J.M.2
Johnson, A.B.3
Catalano, C.4
Cooper, B.G.5
Taylor, R.6
-
32
-
-
84992392013
-
Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: A systematic review of reviews
-
e0162198 27606602 5015869
-
Mandrioli D, Kearns CE, Bero LA. Relationship between research outcomes and risk of bias, study sponsorship, and author financial conflicts of interest in reviews of the effects of artificially sweetened beverages on weight outcomes: a systematic review of reviews. PLoS One. 2016;11(9):e0162198.
-
(2016)
PLoS One
, vol.11
, Issue.9
-
-
Mandrioli, D.1
Kearns, C.E.2
Bero, L.A.3
-
33
-
-
84961175137
-
Metabolic effects of non-nutritive sweeteners
-
26095119 4661066 1:CAS:528:DC%2BC2MXhtVyiu7vP
-
Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav. 2015;152(Pt B):450-5.
-
(2015)
Physiol Behav
, vol.152
, pp. 450-455
-
-
Pepino, M.Y.1
-
34
-
-
85029086845
-
Health outcomes of non-nutritive sweeteners: Analysis of the research landscape
-
28886707 5591507
-
Lohner S, Toews I, Meerpohl JJ. Health outcomes of non-nutritive sweeteners: analysis of the research landscape. Nutr J. 2017;16(1):55.
-
(2017)
Nutr J
, vol.16
, Issue.1
, pp. 55
-
-
Lohner, S.1
Toews, I.2
Meerpohl, J.J.3
-
35
-
-
84978173077
-
Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory
-
27387506 1:CAS:528:DC%2BC28XhtFGrtL3M
-
Shearer J, Swithers SE. Artificial sweeteners and metabolic dysregulation: lessons learned from agriculture and the laboratory. Rev Endocr Metab Disord. 2016;17(2):179-86.
-
(2016)
Rev Endocr Metab Disord
, vol.17
, Issue.2
, pp. 179-186
-
-
Shearer, J.1
Swithers, S.E.2
-
36
-
-
85037611386
-
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-Centre trial
-
29100842
-
Johnsen PH, Hilpusch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-Centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17-24.
-
(2018)
Lancet Gastroenterol Hepatol
, vol.3
, Issue.1
, pp. 17-24
-
-
Johnsen, P.H.1
Hilpusch, F.2
Cavanagh, J.P.3
Leikanger, I.S.4
Kolstad, C.5
Valle, P.C.6
Goll, R.7
-
37
-
-
85040091518
-
Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome
-
29302878
-
Valeur J, Smastuen MC, Knudsen T, Lied GA, Roseth AG. Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Dig Dis Sci. 2018;63(2):429-36.
-
(2018)
Dig Dis Sci
, vol.63
, Issue.2
, pp. 429-436
-
-
Valeur, J.1
Smastuen, M.C.2
Knudsen, T.3
Lied, G.A.4
Roseth, A.G.5
|